SDGR

Vorhandelsmarkt: 24.20 0.03 +0.12%

Schrodinger Inc (SDGR)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SDGR? Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Schrodinger Inc Stock (SDGR) Company Profile

Schrodinger Inc

Healthcare (1154)

503-299-1150

1540 BROADWAY, NEW YORK, NY

@schrodinger

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SDGR's Discussions on Twitter

Vergleichen Sie SDGR mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SDGR Schrodinger Inc	24.17	1.91B	193.35M	-177.58M	-172.43M	-2.45
VEEV Veeva Systems Inc	241.44	38.62B	2.75B	714.14M	1.09B	4.33
DOCS Doximity Inc	61.04	11.14B	516.85M	174.11M	217.38M	0.87
TEM Tempus Ai Inc	62.69	9.36B	640.44M	-743.28M	-206.93M	-11.29
HQY Healthequity Inc	96.66	7.91B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	40.30	7.09B	906.14M	-52.62M	89.62M	-0.3621

Schrodinger Inc Stock (SDGR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-07-02	Eingeleitet	Leerink Partners	Outperform
2023-12-05	Eingeleitet	KeyBanc Capital Markets	Overweight
2023-05-05	Fortgesetzt	Piper Sandler	Overweight
2022-12-19	Eingeleitet	Goldman	Neutral
2022-03-01	Eingeleitet	Citigroup	Buy
2021-11-19	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2021-11-19	Eingeleitet	Piper Sandler	Overweight
2021-11-11	Herabstufung	BofA Securities	Buy → Neutral
2021-10-13	Eingeleitet	Berenberg	Buy
2021-09-01	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2021-05-25	Eingeleitet	Craig Hallum	Buy
2020-11-23	Hochstufung	BofA Securities	Neutral → Buy
2020-10-12	Hochstufung	Jefferies	Hold → Buy
2020-03-02	Eingeleitet	BMO Capital Markets	Outperform
2020-03-02	Eingeleitet	Jefferies	Hold
2020-03-02	Eingeleitet	Morgan Stanley	Equal-Weight

Alle ansehen

Schrodinger Inc Aktie (SDGR) Neueste Nachrichten

Finanzdaten der Schrodinger Inc-Aktie (SDGR)

Schrodinger Inc-Aktie (SDGR) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Akinsanya Karen	President of R&D, Therapeutics	Apr 14 '25	Sale	25.09	16,723	419,570	15,625

Schrodinger Inc (SDGR)

Schrodinger Inc Stock (SDGR) Company Profile

Vergleichen Sie SDGR mit anderen Aktien

Schrodinger Inc Stock (SDGR) Upgrades & Downgrades

Schrodinger Inc Aktie (SDGR) Neueste Nachrichten

Schrödinger, Inc. (NASDAQ:SDGR) Q1 2025 Earnings Call Transcript - Insider Monkey

Schrödinger First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Schrödinger, Inc. Reports Strong Q1 Growth Amid Challenges - TipRanks

Schrodinger Inc (SDGR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... - Yahoo Finance

Schrodinger Inc (SDGR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Advancements - GuruFocus

Decoding Schrodinger Inc (SDGR): A Strategic SWOT Insight - GuruFocus

Schrödinger Q1 2025 slides: revenue jumps 63%, clinical readouts on horizon - Investing.com Canada

Schrödinger projects strong 2025 revenue growth with $45M-$50M in drug discovery - MSN

Schrodinger Inc (SDGR) Q1 2025 Earnings: Revenue Surges to $59.6M, Beating Estimates; Net Loss Widens to $59.8M - GuruFocus

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

Schrodinger Inc reports results for the quarter ended March 31Earnings Summary - TradingView

Earnings call transcript: Schrodinger Q1 2025 beats EPS expectations, stock rises - Investing.com

Schrodinger (SDGR) Surpasses Revenue Expectations with Strong Gr - GuruFocus

Schrodinger (SDGR) Reaffirms 2025 Financial Projections | SDGR Stock News - GuruFocus

Earnings Flash (SDGR) SCHRODINGER Reports Q1 Revenue $59.6M, vs. FactSet Est of $54.7M - marketscreener.com

Schrodinger earnings beat by $0.10, revenue topped estimates - Investing.com

Schrödinger Reports Strong First Quarter 2025 Financial Results - Eagle-Tribune

Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)? - Yahoo Finance

AI Healthcare Boom Gains Speed as Regulators and Innovators Align - Benzinga

Schrödinger to Present at BofA Securities 2025 Healthcare Conference - 01net

Schrödinger to Present at BofA Securities 2025 Healthcare Conference | SDGR Stock News - GuruFocus

Learn to Evaluate (SDGR) using the Charts - news.stocktradersdaily.com

Top 5 AI & Digital Biotech Companies (May 2025) - Securities.io

Schrödinger Demonstrates Corporate Sustainability Progress in 2024 Report - ReportAlert

Schrodinger Inc (SDGR) Shares Gap Down to $25.585 on Apr 28 - GuruFocus

Schrödinger, Inc. (NASDAQ:SDGR) Looks Just Right With A 33% Price Jump - simplywall.st

Schrödinger Presents New Preclinical Data at AACR Annual Meeting - 01net

Schrödinger, Inc. (SDGR): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential - Insider Monkey

Schrödinger to Announce First Quarter 2025 Financial Results on May 7 | SDGR Stock News - GuruFocus

Schrödinger to Announce First Quarter 2025 Financial Results on May 7 - marketscreener.com

3 Momentum Stocks That Could Soar Post-Market Volatility - MarketBeat

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - 01net

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SDGR Stock News - GuruFocus

Schrödinger (NASDAQ:SDGR) shareholders are up 29% this past week, but still in the red over the last five years - simplywall.st

Schrodinger (SDGR) Moves 27.4% Higher: Will This Strength Last? - MSN

An Intrinsic Calculation For Schrödinger, Inc. (NASDAQ:SDGR) Suggests It's 26% Undervalued - Yahoo Finance

Schrodinger price target raised to $32 from $30 at KeyBanc - TipRanks

Schrodinger’s Karen Akinsanya sells $419,570 in stock By Investing.com - Investing.com South Africa

Schrodinger’s Karen Akinsanya sells $419,570 in stock - Investing.com

Schrodinger issues statement on FDA phasing out animal testing requirement - TipRanks

FDA recent move marks paradigm shift in drug development, boosting Schrödinger (SDGR) and other biotech stocks - Investorsobserver

Schrodinger (SDGR) Backs FDA's Initiative to Cut Animal Testing in Drug Development | SDGR Stock News - GuruFocus

Schrödinger's Statement Regarding FDA Plan to Phase Out Animal T - GuruFocus

Schrödinger backs FDA’s move away from animal testing By Investing.com - Investing.com South Africa

Schrodinger to Launch Predictive Toxicology Tool in H2 - marketscreener.com

Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs - 01net

Finanzdaten der Schrodinger Inc-Aktie (SDGR)

Umsatz

Nettogewinn

Free Cashflow

ENV

Schrodinger Inc-Aktie (SDGR) Insiderhandel

Ähnlich wie SDGR